Nuvalent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. 

CEO
James R. Porter
CEOJames R. Porter
Employees
92
Employees92
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
92
Employees92

NUVL Key Statistics

Market cap
4.91B
Market cap4.91B
Price-Earnings ratio
-35.47
Price-Earnings ratio-35.47
Dividend yield
Dividend yield
Average volume
424.79K
Average volume424.79K
High today
$77.58
High today$77.58
Low today
$75.00
Low today$75.00
Open price
$76.85
Open price$76.85
Volume
303.98K
Volume303.98K
52 Week high
$89.39
52 Week high$89.39
52 Week low
$23.10
52 Week low$23.10

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.